Why Is RADNET INC (RDNT) Stock Up Today?

RDNT stock rose 5.09 percent to $74.48 on September 10, 2026, driven by a series of recent developments including a favorable analyst upgrade and a recent earnings beat. The stock opened at $71.20 and climbed steadily throughout the session to reach a high of $74.56. The move reflects investor optimism about the company's recent performance and upcoming events.

What Happened

RadNet, Inc. announced it will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026. The company also scheduled a free prostate cancer webinar for September 19, 2026. These events are expected to increase visibility for the company and highlight its role in diagnostic imaging. Additionally, RadNet reported second-quarter adjusted earnings per share of $0.29, exceeding the $0.20 estimate, and revenue of $622.720 million, beating the $608.711 million forecast. The company also received FDA 510(k) clearance for its AI-powered breast ultrasound, which is expected to be rolled out across its network by year-end.

What The Data Shows

The stock opened at $71.20 and reached a session high of $74.56 at 2:15 PM ET. The volume so far was 0.2 million shares, which is 0.2 times the 3-month daily average. The stock has traded between $50.82 and $85.84 over the past 52 weeks. RadNet has a market cap of $5.7 billion and is currently unprofitable with a trailing twelve-month EPS of -0.27. The company has a net margin of -0.9 percent and a beta of 1.40. Recent insider transactions include three sales totaling $3.0 million, with the most recent filing on June 22, 2026.

What To Watch

Investors should monitor RadNet's upcoming presentation at the Morgan Stanley conference on September 16, 2026, as well as the scheduled webinar on September 19, 2026. These events may provide further insight into the company's strategic direction and growth potential.